📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Jounce Therapeutics Inc (JNCE)

NASDAQ
Currency in USD
Disclaimer
1.880
0.000(0.00%)
Real-time Data

JNCE Comments

Test Can Not SHORT 👉 Never Buy 👉 DELETE
🚀💰
I was ready to dump this stock and was waiting for the 7.45 range so I can break even since May timeline...I never expected the good news today.. this will explode with big pharma investors...I was pleasantly surprised today with this news. this originally had a target price of 9.50 and it should be a good investment for 2021..so hold on for the ride! ..
Worth 0.8B
Gilead signs with Jnce and will pay $35m upfront in shares and later up to $685m royalties, great news for Jnce
hello ! somebody have any new regarding JNCE, will it go up soon?
target: $15
Short this ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.